The researchers from the Revlon/UCLA Women's Cancer Research Program are investigating an experimental drug for the treatment of advanced breast cancer. This resulted in UCLA's Jonsson Comprehensive Cancer Center to receive a "breakthrough therapy" designation from the U. S. Food and Drug Administration.
Initially it was 12 weeks time that was considered safe for using over the counter nicotine gums, patches and lozenges. But now on Monday, the Food and Drug Administration has approved an extended period for the same. FDA said that these over-the-counter products can be used for even a longer period of time but only with a doctor's approval.
A biotechnology firm, Pharmaxis, has received a letter from the US Food and Drug Administration (FDA) regarding a drug that treats cystic fibrosis.
The drug is labeled Bronchitol. This letter is in response to the permission asked by Pharmaxis from the agency. The company wanted the drug to be used by cystic fibrosis patients aged six and above.
U. S. Food and Drug Administration's panel of advisers gave a statement that they no longer support the use and marketing of `calcitonin salmon' for the treatment of osteoporosis in post-menopausal women. The panel voted the drug out of its recommendations that it potentially increases the risk of cancer more than the treatment of osteoporosis by bone-thinning.